CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

NCT04186520 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma (NHL)
Mantle Cell Lymphoma (MCL)
Chronic Lymphocytic Leukemia (CLL)
Follicular Lymphoma
Marginal Zone Lymphoma
Diffuse Large B Cell Lymphoma
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Central Nervous System Lymphoma

Interventions

BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells

Sponsor

Medical College of Wisconsin